24036-47-3 Usage
Uses
Used in Pharmaceutical Research:
6-BROMO-N-METHYL-2H-1,4-BENZOXAZIN-3-ONE is used as a building block for the synthesis of various pharmaceuticals. Its unique chemical properties allow it to be a key component in the development of new drugs, contributing to the advancement of medicine.
Used in Agrochemical Development:
In the agrochemical industry, 6-BROMO-N-METHYL-2H-1,4-BENZOXAZIN-3-ONE serves as a crucial intermediate for the synthesis of agrochemicals. Its role in this field is essential for the creation of new products that can improve agricultural practices and crop protection.
Used in the Development of New Materials:
6-BROMO-N-METHYL-2H-1,4-BENZOXAZIN-3-ONE is also utilized in the development of new materials. Its chemical properties make it suitable for use in the creation of specialty chemicals and other innovative materials that can have various applications across different industries.
Used in Organic Chemistry:
As a synthetic intermediate, 6-BROMO-N-METHYL-2H-1,4-BENZOXAZIN-3-ONE plays a significant role in organic chemistry. It is employed in various chemical reactions and processes, contributing to the synthesis of complex organic compounds and the discovery of new chemical entities.
Check Digit Verification of cas no
The CAS Registry Mumber 24036-47-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,0,3 and 6 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 24036-47:
(7*2)+(6*4)+(5*0)+(4*3)+(3*6)+(2*4)+(1*7)=83
83 % 10 = 3
So 24036-47-3 is a valid CAS Registry Number.
24036-47-3Relevant academic research and scientific papers
Fused Pyrazoles as FGFR Inhibitors
-
Paragraph 0318, (2014/06/25)
The present invention relates to fused pyrazole derivatives, and pharmaceutical compositions including the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
SUBSTITUTED 1-CYANOETHYLHETEROCYCLYLCARBOXAMIDE COMPOUNDS 750
-
Page/Page column 70, (2010/11/18)
The present invention provides compounds of formula (I), in which y, m, n, R1, R2 and Q are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
